YAP1 as a Novel Negative Biomarker of Immune Checkpoint Inhibitors for EGFR-Mutant Non-Small-Cell Lung Cancer

Figure 1

YAP1 is not a prognostic factor of LUAD. (a) The OS had no significant difference between YAP1_High and YAP1_Low lung cancer patients from TCGA LUAD. (b) The EGFR gene regulated YAP1 expression as shown by MR analysis.